跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ROPIBAM 0.2% Ropivacaine hydrochloride 40mg/20mL solution for injection ampoule - TGA Drug Approval Details
Approvals
/
TGA
/
ROPIBAM 0.2% Ropivacaine hydrochloride 40mg/20mL solution for injection ampoule
Approved
STANDARD
ROPIBAM 0.2% Ropivacaine hydrochloride 40mg/20mL solution for injection ampoule
Boucher & Muir Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
b0ce818d3f5ba98e
Company
Boucher & Muir Pty Ltd
Type
Standard
Approval Details
Approval Id
b0ce818d3f5ba98e
Product Name
ROPIBAM 0.2% Ropivacaine hydrochloride 40mg/20mL solution for injection ampoule
Artg Id
186566
Artg Name
ROPIBAM 0.2% Ropivacaine hydrochloride 40mg/20mL solution for injection ampoule
Sponsor
Boucher & Muir Pty Ltd
Company Detail Path
/organization/boucher-and-muir-pty-ltd
Artg Date
2012-03-09
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/e7a825963a6cfb3668ace9f58daa729c.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/d4b13649900bc412af73325273e0fdf9.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
b0ce818d3f5ba98e
Type
Standard
Back to TGA Approvals